It mimics glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), both of which are naturally released during eating
Block absorption
Severe nausea lasting more than 72 hours, vomiting that prevents hydration, signs of pancreatitis (severe abdominal pain radiating to the back), or hypoglycemia symptoms all warrant immediate medical attention
47 The doses of semaglutide available for subcutaneous injection are 0.25 mg, 0.5 mg, 1 mg, or 2 mg for type 2 diabetes, and 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg for obesity, respectively
Tirzepatide vs Semaglutide for Metabolic Research: Compound Specifications The table below summarises the key specifications relevant to laboratory research use